GGrantIndex
← Leaderboards

Homer L Twigg

Indiana Univ-Purdue Univ At Indianapolis

Google Scholar ↗PubMed ↗ORCID ↗
$9,155,869
Attributed
$15,399,803
Total exposure
14
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,399,803 · 14

By mechanism

U01$10,279,338 · 3
R01$2,943,510 · 3
P01$1,110,096 · 1
T32$1,035,179 · 1
M01$31,680 · 6

Top collaborators

Most similar at Indiana Univ-Purdue Univ At Indianapolis

Same institution · by research overlap

Others in their field

Top investigators on “Alveolar Macrophages”

Research focus

Alveolar MacrophagesSamplingClinical ResearchLeadBloodCytokineInflammatoryCohortChronicInflammationImmunityLungHiv InfectionsHuman SubjectVirus DiseasesBronchoalveolar LavageImmuneT-LymphocyteUniversitiesIndianaViral Load ResultMolecularImmunosenescenceResources

Grant awards (46)

Analysis of immunologic mechanisms in patients with chronic lung disease after acute COVID infection$727,528
R01 · FY2025 · HL · contact PI
Research Bronchoscopy and Biospecimens Core$209,710
P01 · FY2025 · HL · contact PI
Analysis of immunologic mechanisms in patients with chronic lung disease after acute COVID infection$752,410
R01 · FY2024 · HL · contact PI
Research Bronchoscopy and Biospecimens Core$191,153
P01 · FY2024 · HL · contact PI
Research Bronchoscopy and Biospecimens Core$203,322
P01 · FY2023 · HL · contact PI
Viral burden and systemic inflammation as biomarkers for chronic disease and frailty in aging$649,153
U01 · FY2022 · AG · contact PI
Research Bronchoscopy and Biospecimens Core$203,322
P01 · FY2022 · HL · contact PI
Viral burden and systemic inflammation as biomarkers for chronic disease and frailty in aging$652,505
U01 · FY2021 · AG · contact PI
Research Bronchoscopy and Biospecimens Core$302,589
P01 · FY2021 · HL · contact PI
Viral burden and systemic inflammation as biomarkers for chronic disease and frailty in aging$655,655
U01 · FY2020 · AG · contact PI
Viral burden and systemic inflammation as biomarkers for chronic disease and frailty in aging$660,380
U01 · FY2019 · AG · contact PI
Viral burden and systemic inflammation as biomarkers for chronic disease and frailty in aging$153,823
U01 · FY2019 · AG · contact PI
Viral burden and systemic inflammation as biomarkers for chronic disease and frailty in aging$692,280
U01 · FY2018 · AG · contact PI
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$631,713
U01 · FY2017 · HL · contact PI
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$632,227
U01 · FY2016 · HL · contact PI
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$634,026
U01 · FY2015 · HL · contact PI
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$622,323
U01 · FY2014 · HL · contact PI
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$641,507
U01 · FY2013 · HL · contact PI
Lung Microbiome and Pulmonary Inflammation/Immunity in HIV Infection$639,466
U01 · FY2013 · HL · contact PI
Lung Microbiome and Pulmonary Inflammation/Immunity in HIV Infection$735,715
U01 · FY2012 · HL · contact PI
Lung Microbiome and Pulmonary Inflammation/Immunity in HIV Infection$744,070
U01 · FY2011 · HL · contact PI
Lung Microbiome and Pulmonary Inflammation/Immunity in HIV Infection$755,004
U01 · FY2010 · HL · contact PI
Lung Microbiome and Pulmonary Inflammation/Immunity in HIV Infection$779,491
U01 · FY2009 · HL · contact PI
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY FUNCTION IN HIV$3,407
M01 · FY2008 · RR · contact PI
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY FUNCTION IN HIV$14,291
M01 · FY2007 · RR · contact PI
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY FUNCTION IN HIV$4,386
M01 · FY2006 · RR · contact PI
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY FUNCTION IN HIV$5,560
M01 · FY2005 · RR
Mechanisms Underlying Enhanced Alveolar Macrophage Accessory Function in HIV...$2,481
M01 · FY2004 · RR
Effect of HAART on viral burden &immune function in lungs of HIV infected pts.$1,555
M01 · FY2004 · RR
TRAINING GRANT ON LUNG PATHOPHYSIOLOGY$380,651
T32 · FY2002 · HL
PROGRESSIVE IMPAIRMENT OF LUNG IMMUNITY IN HIV INFECTION$248,992
R01 · FY2002 · HL
PULMONARY HUMORAL IMMUNE RESPONSES IN HIV INFECTION$218,049
R01 · FY2002 · HL
PULMONARY HUMORAL IMMUNE RESPONSES IN HIV INFECTION$75,000
R01 · FY2002 · HL
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY CELL FUNCTION$0
M01 · FY2002 · RR
TRAINING GRANT ON LUNG PATHOPHYSIOLOGY$391,507
T32 · FY2001 · HL
PROGRESSIVE IMPAIRMENT OF LUNG IMMUNITY IN HIV INFECTION$245,194
R01 · FY2001 · HL
PULMONARY HUMORAL IMMUNE RESPONSES IN HIV INFECTION$217,665
R01 · FY2001 · HL
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY CELL FUNCTION$0
M01 · FY2001 · RR
TRAINING GRANT ON LUNG PATHOPHYSIOLOGY$263,021
T32 · FY2000 · HL
PROGRESSIVE IMPAIRMENT OF LUNG IMMUNITY IN HIV INFECTION$241,330
R01 · FY2000 · HL
PULMONARY HUMORAL IMMUNE RESPONSES IN HIV INFECTION$217,342
R01 · FY2000 · HL
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY CELL FUNCTION$0
M01 · FY2000 · RR
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY CELL FUNCTION$0
M01 · FY2000 · RR
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY CELL FUNCTION$0
M01 · FY2000 · RR
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY CELL FUNCTION$0
M01 · FY2000 · RR
MECHANISMS UNDERLYING ENHANCED ALVEOLAR MACROPHAGE ACCESSORY CELL FUNCTION$0
M01 · FY2000 · RR